HYPERGEN--GENETICS OF LEFT VENTRICULAR HYPERTROPHY

HYPERGEN--左心室肥大的遗传学

基本信息

  • 批准号:
    2750535
  • 负责人:
  • 金额:
    $ 43.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1996
  • 资助国家:
    美国
  • 起止时间:
    1996-08-10 至 2000-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (Adapted from the Investigator's Abstract) Studies of left ventricular (LV) hypertrophy detected by echocardiography demonstrate its importance in cardiovascular morbidity and mortality, independent of blood pressure and other cardiovascular risk factors. The goal of this project is to evaluate the genetic determinants of LV hypertrophy. Building upon HyperGEN (a network established to investigate the genetic determinants of hypertension as part of the NHLBI Genetic Determinants of High Blood Pressure RFA (#6-94-011), this application proposes to perform a targeted echocardiographic examination on 2,575 HyperGEN participants in four field centers as part of the HyperGEN clinical examination. The HyperGEN study is designed to identify the genetic determinants of hypertension by selecting severely and mildly affected hypertensives from existing epidemiologic populations, affected siblings of these probands, a random sample of individuals from the cohorts, and normotensive relatives of the probands. These individuals will be examined over a three year period, beginning in August, 1996. There are five specific aims for this echocardiography project. First, the investigators will characterize LV structure and function in 2,575 individuals. Second, they will define LV structural phenotypes based on four geometric patterns(normal geometry, concentric remodeling, concentric LV hypertrophy, and eccentric LV hypertrophy). Third, they will examine a highly select group of candidate genes and their association with LV mass (measured as a quantitative trait to increase statistical power) and geometric patterns. Fourth, using quantitative trait loci analyses, the investigators will test for linkage of 240 anonymous, evenly spaced genetic markers with LV mass and geometric patterns. The fifth aim is to evaluate interactions between genes and potential risk factors for LV hypertrophy (insulin, glucose, blood pressure response to mental and physical stressors, dietary and urinary electrolytes, obesity) and LV mass and geometry. The proposed project has the advantages of (i) incorporation into an already funded study designed to examine. the genetic determinants of hypertension (more than 500,000 individual genotypes are measured as part of HyperGEN); (ii) recruitment of participants from on-going population-based studies of well-characterized cohorts; (iii) collaboration with experienced investigators in research echocardiography, an experienced echocardiography reading center (under the direction of Dr. Richard Devereux), statistical expertise in association and linkage analyses (directed by Dr. D. C. Rao), and genetic testing by a state-of-the-art laboratory(directed by Dr. Lalouel). It will, therefore, be an important and cost-effective contribution to the knowledge and understanding about the genetics of LV hypertrophy.
描述:(改编自研究者摘要)左 超声心动图检测到的心室(LV)肥大表明其 在心血管发病率和死亡率中的重要性,与血液无关 压力和其他心血管风险因素。 这个项目的目标是 评估左心室肥大的遗传决定因素。 基础上 HyperGEN(一个网络,建立调查的遗传决定因素, 高血压作为NHLBI高血压遗传决定因素的一部分 压力RFA(#6-94-011),本申请建议进行靶向 在四个领域对2,575名HyperGEN参与者进行超声心动图检查 作为HyperGEN临床检查的一部分。 HyperGEN研究旨在确定以下遗传决定因素: 高血压,选择严重和轻度影响的高血压患者, 现有的流行病学人群,这些先证者的受影响兄弟姐妹, 从队列中随机抽取个体,和血压正常的亲属, 先证者 这些人将在三年内接受审查, 从1996年8月开始。 本超声心动图项目有五个具体目标。 一是 研究人员将在2575例患者中描述LV结构和功能 个体 其次,他们将根据以下因素定义LV结构表型: 四种几何图案(正常几何形状、同心重塑、同心 LV肥大和离心性LV肥大)。 第三,他们将研究一个 高度选择候选基因组及其与LV质量的关联 (作为一种数量性状来衡量,以增加统计能力)和 几何图案 第四,使用数量性状基因座分析, 研究人员将测试240个匿名的,均匀分布的遗传基因的连锁。 左心室质量和几何模式的标记。 第五个目标是评估 基因与左心室肥大潜在危险因素之间的相互作用 (胰岛素、葡萄糖、血压对精神和身体压力的反应, 饮食和尿电解质、肥胖)和LV质量和几何形状。 建议的项目有以下优点:(i)纳入一个已 资助的研究,旨在检查。 高血压的遗传决定因素 (more超过500,000个个体基因型作为HyperGEN的一部分进行测量); (ii)从正在进行的基于人群的研究中招募参与者, (三)与有经验的专家合作; 研究超声心动图的研究者,一位经验丰富的超声心动图 阅读中心(Richard Devereux博士指导下),统计学 关联和联系分析的专业知识(由D. C. Rao), 和基因检测由国家的最先进的实验室(由博士指导, Lalouel)。 因此,这将是一个重要的和具有成本效益的 对LV遗传学知识和理解的贡献 肥厚

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Donna K Arnett其他文献

1030-139 Prevalence and correlates of mitral regurgitation in hypertensive patients: The hypergen study
  • DOI:
    10.1016/s0735-1097(04)91806-2
  • 发表时间:
    2004-03-03
  • 期刊:
  • 影响因子:
  • 作者:
    Zhi Bin Li;Richard B Devereux;Jennifer E Liu;Dalane W Kitzman;Albert Oberman;Paul N Hopkins;Charles C Gu;Donna K Arnett
  • 通讯作者:
    Donna K Arnett
1142-179 Body fat distribution influences cardiac output in normotensive and hypertensive overweight individuals: The hyperGEN study
  • DOI:
    10.1016/s0735-1097(04)92168-7
  • 发表时间:
    2004-03-03
  • 期刊:
  • 影响因子:
  • 作者:
    Giovanni de Simone;Richard B Devereux;Marcello Chinali;Vittorio Palmieri;Albert Oberman;Dalane W Kitzman;Paul N Hopkins;D.C Rao;Donna K Arnett
  • 通讯作者:
    Donna K Arnett

Donna K Arnett的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Donna K Arnett', 18)}}的其他基金

Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate
膳食脂肪和非诺贝特脂质反应的表观遗传决定因素
  • 批准号:
    9250286
  • 财政年份:
    2016
  • 资助金额:
    $ 43.3万
  • 项目类别:
Genetic and Molecular Markers of Methotrexate Efficacy and Toxicity in Early...
早期甲氨蝶呤功效和毒性的遗传和分子标记...
  • 批准号:
    8304146
  • 财政年份:
    2011
  • 资助金额:
    $ 43.3万
  • 项目类别:
Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate
膳食脂肪和非诺贝特脂质反应的表观遗传决定因素
  • 批准号:
    8300134
  • 财政年份:
    2010
  • 资助金额:
    $ 43.3万
  • 项目类别:
Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate
膳食脂肪和非诺贝特脂质反应的表观遗传决定因素
  • 批准号:
    8509004
  • 财政年份:
    2010
  • 资助金额:
    $ 43.3万
  • 项目类别:
Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate
膳食脂肪和非诺贝特脂质反应的表观遗传决定因素
  • 批准号:
    8130808
  • 财政年份:
    2010
  • 资助金额:
    $ 43.3万
  • 项目类别:
Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate
膳食脂肪和非诺贝特脂质反应的表观遗传决定因素
  • 批准号:
    9120549
  • 财政年份:
    2010
  • 资助金额:
    $ 43.3万
  • 项目类别:
Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate
膳食脂肪和非诺贝特脂质反应的表观遗传决定因素
  • 批准号:
    7949793
  • 财政年份:
    2010
  • 资助金额:
    $ 43.3万
  • 项目类别:
Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat
非诺贝特和膳食脂肪的脂质反应的全基因组关联研究
  • 批准号:
    8129753
  • 财政年份:
    2008
  • 资助金额:
    $ 43.3万
  • 项目类别:
Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat
非诺贝特和膳食脂肪的脂质反应的全基因组关联研究
  • 批准号:
    9316688
  • 财政年份:
    2008
  • 资助金额:
    $ 43.3万
  • 项目类别:
Genetic and Molecular Markers of Methotrexate Efficacy and Toxicity in Early...
早期甲氨蝶呤功效和毒性的遗传和分子标记...
  • 批准号:
    7475994
  • 财政年份:
    2008
  • 资助金额:
    $ 43.3万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.3万
  • 项目类别:
    Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 43.3万
  • 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 43.3万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 43.3万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 43.3万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 43.3万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 43.3万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 43.3万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 43.3万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 43.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了